HIV Assay Longitudinal Specificity Study

HIV longitudinal
HIV longitudinal Icon

Thanks to the evolution of diagnostic testing technology, modern HIV serological screening assays have extremely high analytical and clinical sensitivity and are able to detect acute HIV earlier than ever.

But what about assay specificity? High specificity is key to reducing false-positive results, helping labs minimize costly and time-consuming repeat and supplemental testing.

This webinar discusses a long-term longitudinal specificity study of the BioPlex™ 2200 HIV Ag-Ab panel. Over 150,000 specimens from a high-risk population were analyzed over a 4-year period.

Learn how the BioPlex 2200 Ag-Ab panel minimizes false-positive results.

Fill out the form to watch the webinar.